/ Print /

Business Strategy

Five things to know about Trump’s health leadership picksPresident-elect Trump named Tom Price and Seema Verma to lead HHS and CMS, respectively. Here’s what you should know about them.
Opinion: Health reformers overlook areas that could reduce most costsNone of Trump’s plans, such as repealing parts of Obamacare or expanding HSAs, will rein in the rising cost of healthcare.
Top barriers to fully utilizing precision medicine biomarkersAs development of molecular biomarkers hastens, administrators, clinicians and regulators are working to organize and define biomarkers’ appropriate roles in clinical care—and discussing how to efficiently share the massive amounts of genomic data that will result.
Four innovative models rein in pharma costs
Four innovative models rein in pharma costsPlans and PBMs are finding new ways to rein in pharmacy costs.
New funding mechanisms offer opportunity to improve access to diabetes educationTelephonic and personalized diabetes self-education programs which fit into patient’s busy lives will make a greater impact than in-person classes only.
Trend to watch: Payer-provider joint venturesJoint ventures are gaining steam as health plans and providers look for new ways to work together.
Women’s health Q&A: Two specialists discuss top issuesTwo experts discuss top-of-mind women’s healthcare issues in managed care.
Four ways to get your data analytics team up to speed
Four ways to get your data analytics team up to speedDoes your analytics team have what it takes? Experts share their top recommendations.
Integrating pharmacy benefit, medical benefit cuts costsHere’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.
Program prevents, delays new cases of type 2 diabetes by 58%Leader of the YMCA’s Diabetes Prevention Program explains how it is improving diabetes care.